Ultralife (ULBI) Competitors $8.80 -0.22 (-2.44%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$8.56 -0.24 (-2.67%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ULBI vs. AMPX, BLDP, SLDP, SES, RONI, EAF, FREY, NVX, GAUZ, and ZEOShould you be buying Ultralife stock or one of its competitors? The main competitors of Ultralife include Amprius Technologies (AMPX), Ballard Power Systems (BLDP), Solid Power (SLDP), SES AI (SES), Rice Acquisition Corp. II (RONI), GrafTech International (EAF), FREYR Battery (FREY), NOVONIX (NVX), Gauzy (GAUZ), and Zeo Energy (ZEO). These companies are all part of the "electrical equipment" industry. Ultralife vs. Its Competitors Amprius Technologies Ballard Power Systems Solid Power SES AI Rice Acquisition Corp. II GrafTech International FREYR Battery NOVONIX Gauzy Zeo Energy Ultralife (NASDAQ:ULBI) and Amprius Technologies (NYSE:AMPX) are both small-cap electrical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings. Which has more risk and volatility, ULBI or AMPX? Ultralife has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, Amprius Technologies has a beta of 2.68, meaning that its share price is 168% more volatile than the S&P 500. Do insiders & institutionals believe in ULBI or AMPX? 30.7% of Ultralife shares are owned by institutional investors. Comparatively, 5.0% of Amprius Technologies shares are owned by institutional investors. 40.0% of Ultralife shares are owned by company insiders. Comparatively, 12.9% of Amprius Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to ULBI or AMPX? In the previous week, Amprius Technologies had 4 more articles in the media than Ultralife. MarketBeat recorded 6 mentions for Amprius Technologies and 2 mentions for Ultralife. Ultralife's average media sentiment score of 1.92 beat Amprius Technologies' score of 0.61 indicating that Ultralife is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ultralife 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Amprius Technologies 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer ULBI or AMPX? Ultralife presently has a consensus price target of $14.00, indicating a potential upside of 59.09%. Amprius Technologies has a consensus price target of $9.50, indicating a potential upside of 116.89%. Given Amprius Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Amprius Technologies is more favorable than Ultralife.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ultralife 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Amprius Technologies 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Is ULBI or AMPX more profitable? Ultralife has a net margin of 3.05% compared to Amprius Technologies' net margin of -133.34%. Ultralife's return on equity of 4.61% beat Amprius Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Ultralife3.05% 4.61% 3.16% Amprius Technologies -133.34%-67.67%-38.69% Which has better valuation & earnings, ULBI or AMPX? Ultralife has higher revenue and earnings than Amprius Technologies. Amprius Technologies is trading at a lower price-to-earnings ratio than Ultralife, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUltralife$164.46M0.89$6.31M$0.3227.50Amprius Technologies$24.17M21.37-$44.67M-$0.41-10.68 SummaryUltralife beats Amprius Technologies on 10 of the 17 factors compared between the two stocks. Get Ultralife News Delivered to You Automatically Sign up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ULBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ULBI vs. The Competition Export to ExcelMetricUltralifeELEC IndustryComputer SectorNASDAQ ExchangeMarket Cap$150.03M$5.23B$27.19B$8.87BDividend YieldN/A2.96%3.15%4.10%P/E Ratio27.5031.5136.0319.90Price / Sales0.892.231,990.56113.66Price / Cash12.7222.1837.6556.90Price / Book1.092.257.065.38Net Income$6.31M$171.53M$763.02M$248.50M7 Day Performance7.84%-0.84%1.86%2.04%1 Month Performance21.38%5.74%5.94%4.84%1 Year Performance-15.87%-1.34%52,289.36%20.23% Ultralife Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ULBIUltralife3.9029 of 5 stars$8.80-2.4%$14.00+59.1%-17.2%$150.03M$164.46M27.50560Positive NewsAMPXAmprius Technologies3.3309 of 5 stars$4.24+4.2%$9.50+124.1%+254.7%$479.96M$24.17M-10.3450News CoveragePositive NewsGap DownBLDPBallard Power Systems2.2609 of 5 stars$1.59+8.9%$2.09+31.4%-23.0%$437.78M$69.73M-1.561,370SLDPSolid Power0.5967 of 5 stars$2.19+1.9%$1.50-31.5%+51.5%$385.63M$20.14M-4.29240News CoverageHigh Trading VolumeSESSES AI2.5813 of 5 stars$0.89+0.3%$1.50+68.5%-19.4%$325.55M$2.04M-2.97130RONIRice Acquisition Corp. IIN/A$2.48+4.2%N/A-71.9%$299.47MN/A0.0024Gap DownHigh Trading VolumeEAFGrafTech International1.489 of 5 stars$0.98-7.5%$1.63+65.8%-3.1%$273.60M$538.78M-1.811,072FREYFREYR Battery1.9953 of 5 stars$1.25-3.8%$4.00+220.0%-20.4%$175.61MN/A-1.64210Negative NewsGap DownNVXNOVONIX1.0079 of 5 stars$1.01-2.4%N/A-38.8%$164.60M$5.85M0.00N/AGAUZGauzy3.3772 of 5 stars$8.44-1.7%$13.50+60.0%-29.0%$163.68M$103.53M-2.07N/AZEOZeo Energy1.263 of 5 stars$2.90-4.0%N/A+10.4%$148.90M$73.24M-5.09N/AGap Up Related Companies and Tools Related Companies Amprius Technologies Competitors Ballard Power Systems Competitors Solid Power Competitors SES AI Competitors Rice Acquisition Corp. II Competitors GrafTech International Competitors FREYR Battery Competitors NOVONIX Competitors Gauzy Competitors Zeo Energy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ULBI) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ultralife Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Ultralife With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ULBI Stock Alerts